Orphanet: Networks
x

Search for a networks

* (*) mandatory field

Phase II, multicenter, randomized, adaptive, double-blind, placebo controlled study to assess safety and efficacy of olesoxime (TRO19622) in 3-25 year old Spinal Muscular Atrophy (SMA) patients - coordination

  • Type of network : Multinational clinical trials
  • Geographic coverage : European
  • Funding body(ies) : -
  • Sponsor : TROPHOS SA
  • Website
  • Coordinator of multinational clinical trial

  • Pr Enrico S. BERTINI
  • Ospedale Pediatrico Bambino Ges¨
  • IRCCS Ospedale Pediatrico Bambino Ges¨ - SEDE GIANICOLO
  • Piazza S. Onofrio 4
  • 00165 ROMA RM
  • ITALY
  • More information
  • Phone  : 39 06 68591
  • Fax  : -
  • Website
  • Sponsor of multinational clinical trial

  • TROPHOS SA
  • Trophos SA
  • Roche
  • Parc scientifique et technologiques de Luminy
  • 163 Avenue de Luminy
  • 13288 MARSEILLE CEDEX 9
  • FRANCE
  • More information
  • Phone  : 33 (0)4 91 82 82 82
  • Fax  : 33 (0)4 91 82 82 89
  • Website
Last update: June 2017

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.